Paces Ferry Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Paces Ferry Wealth Advisors, LLC
- $196 Million
- Q4 2024
A detailed history of Paces Ferry Wealth Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Paces Ferry Wealth Advisors, LLC holds 1,236 shares of VRTX stock, worth $633,116. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,236
Previous 1,294
4.48%
Holding current value
$633,116
Previous $601,000
17.3%
% of portfolio
0.25%
Previous 0.35%
Shares
16 transactions
Others Institutions Holding VRTX
# of Institutions
1,763Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.5 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.14 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.34 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...